Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Gamida Cell Ltd. < Previous 1 2 Next > Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201 October 16, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell Issues Update on Israel Operations October 09, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa October 02, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting September 28, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA First Patient Receives Gamida Cell's Omisirge™ (omidubicel-onlv) September 27, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell to Present Corporate Highlights at the H.C. Wainwright 25th Annual Global Investment Conference August 31, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update August 14, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell to Report Second Quarter 2023 Financial Results August 01, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Data Published in Transplantation and Cellular Therapy Suggest Antiviral Protection After Transplantation with Gamida Cell’s Omisirge® (omidubicel-onlv) July 11, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference May 31, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Data To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual Meeting May 31, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell Appoints Terry Coelho as CFO May 22, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update May 15, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast May 11, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell Announces Pricing of $23 Million Public Offering of Securities April 19, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell Announces Launch of Public Offering of Securities April 18, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval April 17, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update March 27, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell Announces Changes to Board of Directors March 20, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell Announces the Date of Its Fourth Quarter and Full Year 2022 Financial Results and Webcast March 20, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell to Present Corporate Highlights at the Oppenheimer 33rd Annual Healthcare Conference March 07, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Data Presented on Gamida Cell’s Omidubicel, GDA-201 at the 2023 Tandem Meetings of ASTCT and CIBMTR February 18, 2023 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell Announces Closing of $25 Million Financing With Highbridge December 12, 2022 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences November 23, 2022 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell Provides Regulatory Update on Omidubicel November 21, 2022 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell Reports Third Quarter 2022 Financial Results and Provides Company Update November 14, 2022 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell to Present Corporate Highlights at the Jefferies London Healthcare Conference November 10, 2022 From Gamida Cell Ltd. Via Business Wire Tickers GMDA GDA-501, NAM enabled NK Cell Therapy, Demonstrates Promising Antitumor Activity Against HER2+ Cancers November 07, 2022 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell Announces the Date of Its Third Quarter 2022 Financial Results and Webcast November 07, 2022 From Gamida Cell Ltd. Via Business Wire Tickers GMDA Gamida Cell Announces Omidubicel Data To Be Presented as an Oral Presentation at 64th ASH Annual Meeting November 03, 2022 From Gamida Cell Ltd. Via Business Wire Tickers GMDA < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.